NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

I agree, and said as much when the 10k first came out. But that doesn't stop NWBO from simply saying it was "accepted for review". Yup more games, agree again.

>>EQRx – a focused on expanding access to innovative medicines – has announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has accepted a marketing authorisation application (MAA) for sugemalimab.

>>Melanie Nallicheri, president and chief executive officer at EQRx, reflected: “With the acceptance of this application, we now have two investigational therapies under review with the MHRA in non-small cell lung cancer,